Trial Condition(s):
CE in MRI: Liver
Primovist: DDI with OATP-Inhibitor
Bayer Identifier:
13358
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
EU CT Number:
Not Available
Study Completed
Trial Purpose
Please see attached Study Results Summary below
Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available
Trial Summary
Enrollment Goal
12
Trial Dates
Phase
1
Could I receive a placebo?
No
Products
Eovist/Primovist (Gadoxetate disodium, BAY86-4873)
Accepts Healthy Volunteers
N/A
Where to Participate
Loading...
Locations
| Locations | |
|---|---|
Locations Bayer Schering Pharma AG Berlin, Germany, 13353 | Contact Us: E-mail: [email protected] Phone: Not Available |
For details, please refer to trial results
Additional Information
Copyright © Bayer
Powered by
